Russell Pachynski, MD

Articles by Russell Pachynski, MD

Russell Pachynski, MD, associate professor of medicine, Division of Medical Oncology, Washington University School of Medicine in St Louis, medical oncologist, Siteman Cancer Center

Dr Pachynski on the Ongoing Investigation of ARX517 in Advanced Solid Tumors

ByRussell Pachynski, MD

October 17th 2023

Russell Pachynski, MD, discusses the ongoing investigation of ARX517 in patients with advanced solid tumors in the phase 1/2 APEX-01 trial.

Latest Updated Articles

Trending on OncLive

FDA Flashback: Hematologic Cancer Decisions and News From October 2026

Dr Negrao on Olomorasib Plus Chemoimmunotherapy in KRAS G12C–Mutant NSCLC

Nogapendekin Alfa Inbakicept Plus BCG Meets Primary End Point in BCG-Naive NMIBC

Gedatolisib sNDA Accepted by FDA for PIK3CA-Mutated, HR+, HER2– Advanced Breast Cancer

Melflufen Gains EU Expansion in Third-Line Lenalidomide-Refractory Multiple Myeloma